Can-Fite BioPharma News

Can-Fite BioPharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)

Feb 15 04:34

Can-Fite BioPharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CVI Investments, Inc.(3.7%),Heights Capital Management, Inc.(3.7%)

Feb 15, 2022 04:23

Can-Fite BioPharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%), etc.

Feb 11, 2022 19:52

Can-Fite BioPharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hudson Bay Capital Management LP(4.08%),Sander Gerber(4.08%)

Feb 5, 2022 04:59

Can-Fite BioPharma | D: Filing D

Dec 31, 2021 05:15

Can-Fite BioPharma | D: Filing D

Aug 27, 2021 04:30

Can-Fite BioPharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 16, 2021 22:54

Can-Fite BioPharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 9, 2021 07:04

Can-Fite BioPharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Jan 29, 2021 19:51

Can-Fite BioPharma | D: Filing D

Jul 18, 2020 04:30

Can-Fite BioPharma | D: Filing D

Jun 20, 2020 04:35

Can-Fite BioPharma | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Jun 20, 2020 04:23

Can-Fite BioPharma | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Jun 19, 2020 18:02

Can-Fite BioPharma | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 21, 2020 05:24

Can-Fite BioPharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 15, 2020 06:11

Can-Fite BioPharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Feb 11, 2020 19:13

Can-Fite BioPharma | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 1, 2020 04:34

Can-Fite BioPharma | D: Filing D

Jan 25, 2020 05:40

Can-Fite BioPharma | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)

Jan 9, 2020 06:21

Can-Fite BioPharma | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)

Oct 24, 2019 22:49